Find activities

88 results

  • REGISTER for "Enhancing HTA - 2025 Reflections" Consumer Webinar, 3 December 2025

    The HTA Consumer Consultative Committee (CCC) invites representatives of health consumer organisations to a free webinar. "Enhancing HTA - 2025 Reflections" 11:00am - 12:30pm (AEDT), Wednesday 3 December 2025 About the webinar: Hosted by the Chair of the HTA-CCC, Jo Watson, this 90-minute webinar will reflect on highlights of consumer sector activities in HTA during 2025. It will also look towards consumer engagement opportunities in 2026. Speakers will include... More
    Opened 29 October 2025

  • MSAC Consultation Survey - Application 1790

    MSAC application 1790 POLE genotyping for the molecular classification of endometrial cancer. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care environment. It... More
    Opened 22 October 2025

  • MSAC Consultation Survey - Application 1796

    MSAC application 1796 ADAMTS13 testing for the diagnosis of thrombotic thrombocytopenic purpura (TTP). Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care ... More
    Opened 22 October 2025

  • MSAC Consultation Survey - Application 1804

    MSAC application 1804 - Genetic testing to detect RET variants in patients with medullary thyroid cancer to determine eligibility for PBS subsidised selpercatinib treatment. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed... More
    Opened 22 October 2025

  • MSAC Consultation Survey - Application 1805

    MSAC application 1805 - Concizumab for routine prophylaxis to prevent bleeding in patients with haemophilia B. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care ... More
    Opened 22 October 2025

  • MSAC Consultation Survey - Application 1806

    MSAC application 1806 - Marstacimab for routine prophylaxis to prevent bleeding in patients with haemophilia. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care ... More
    Opened 22 October 2025

  • MSAC Consultation Survey - Application 1657.1

    MSAC application 1657.1 Rhenium-188 brachytherapy for non-melanoma skin cancer. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care environment. It does this by... More
    Opened 22 October 2025

  • MSAC Consultation Survey - Application 1779.1

    MSAC application 1779.1 Testing of tumour tissue to detect FGFR2 fusions or rearrangements in people with cholangiocarcinoma, to determine eligibility for treatment with PBS subsidised futibatinib. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better... More
    Opened 1 October 2025

  • HTA Review Implementation Advisory Group Draft Roadmap - Webinar Registration

    The Health Technology Assessment Review Implementation Advisory Group (the IAG) is now developing its advice on a draft implementation roadmap for government consideration and invites you to attend a webinar hosted by the IAG Chair, Professor Andrew Wilson and contribute to this process. The session will provide insights into the IAG’s development of the roadmap and the proposed approach to the prioritisation of actions. Following the webinar, a short survey will be sent to... More
    Opened 30 September 2025

  • MSAC Consultation Survey - Application 1811

    MSAC application 1811 Testing for MET overexpression and amplification in patients with locally advanced or metastatic non-small cell lung cancer to determine eligibility for treatment with PBS subsidised savolitinib in combination with osimertinib. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input ... More
    Opened 26 September 2025

  • MSAC Consultation Survey - Application 1809

    MSAC application 1809 Genomic testing in cancer of unknown primary (CUP) and diagnostically challenging cancers. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care ... More
    Opened 26 September 2025

  • MSAC Consultation Survey - Application 1812

    MSAC application 1812 Transcatheter Edge-To-Edge Repair (TEER) for the treatment of severe tricuspid regurgitation (TR) using the TriClip device. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology... More
    Opened 26 September 2025

  • MSAC Consultation Survey - Application 1810

    MSAC application 1810 Genomic testing for the diagnosis of primary immunodeficiency (PID). Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care environment. It does... More
    Opened 26 September 2025

  • REGISTER for "Enhancing HTA Feedback - From HTA Inputs to Outcomes" Consumer Webinar, 1 October 2025

    The HTA Consumer Consultative Committee (CCC) invites representatives of health consumer organisations to a free webinar. “Enhancing HTA Feedback - From HTA Inputs to Outcomes” HTA inputs/outcomes in relation to the Pharmaceutical Benefits Advisory Committee (PBAC) and the Medical Services Advisory Committee (MSAC) 11:00am – 12:30pm AEST, Wednesday 1 October 2025 About the webinar: HTA Committees seek input from... More
    Opened 1 September 2025

  • Public consultation on items to be considered by the PBAC (Nov 2025)

    Consultation has opened for the November 2025 Pharmaceutical Benefits Advisory Committee (PBAC) agenda. The PBAC welcomes input from patients, carers, health professionals, consumer groups or organisations and members of the public on medicines and vaccines submitted for PBAC consideration. The PBAC considers these public consultation inputs when considering the clinical and economic evidence presented by the applicant. Information provided by consumers helps the committee... More
    Opened 30 July 2025

  • MSAC Consultation Survey - Application 1799

    MSAC application 1799 - Transcatheter tricuspid valve replacement in patients with severe, symptomatic tricuspid regurgitation despite optimal medical therapy. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service... More
    Opened 25 June 2025

  • MSAC Consultation Survey - Application 1797

    MSAC application 1797 - Vibration-Controlled Transient Elastography (VCTE™) for identifying advanced fibrosis in patients with metabolic dysfunction-associated fatty liver disease. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a... More
    Opened 25 June 2025

  • MSAC Consultation Survey - Application 1798

    MSAC application 1798 - Liquid biopsy genetic testing in patients with non-small cell lung cancer. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care ... More
    Opened 25 June 2025

  • MSAC Consultation Survey - Application 1752

    MSAC application 1752 - Anal human papillomavirus (HPV) and cytology testing in high-risk populations to determine access to high-resolution anoscopy and ablative treatment to prevent anal cancer. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better... More
    Opened 25 June 2025

  • REGISTER for "Consumer Inputs for HTA Committees' considerations" Consumer Webinar, 23 July 2025

    The Chair of the Health Technology Assessment (HTA) Consumer Consultative Committee (CCC), Adjunct Associate Professor Jo Watson, invites health consumers and health consumer organisations to a free webinar: "Enhancing HTA - Consumer Inputs for HTA Committees' considerations" HTA Committees include the Pharmaceutical Benefits Advisory Committee (PBAC) and the Medical Services Advisory Committee (MSAC). 11:00am – 12:30pm (AEST), Wednesday 23 July 2025 ... More
    Opened 12 June 2025

  • CEEU/HTA Updates

    Receive regular HTA Engage e-newsletters for updates on HTA activities and announcements from the CEEU, including open consultation dates for PBAC and MSAC meeting agenda items. More
    Opened 1 June 2025

  • MSAC Updates

    Subscribe to MSAC email bulletins on the MSAC meeting agendas and consultations, and important updates. More
    Opened 1 June 2025

  • PBAC Updates

    Subscribe to PBS.gov.au email notification of the Pharmaceutical Benefits Scheme (PBS) news, including PBAC meeting agendas, consultations and outcomes. More
    Opened 1 June 2025

  • MSAC Consultation Survey - Application 1803

    MSAC application 1803 - Implantation of an active middle ear implant (Vibroplasty) for treatment of mixed and conductive hearing loss. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the... More
    Opened 30 May 2025

  • MSAC Consultation Survey - Application 1802

    MSAC application 1802 - Supervised oral food challenge (OFC) in patients with suspected food allergy. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care ... More
    Opened 30 May 2025

  • MSAC Consultation Survey - Application 1808

    MSAC application 1808 - IncobotulinumtoxinA (XEOMIN) injection codes for cerebral palsy spasticity of the lower and/or upper limbs. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the... More
    Opened 30 May 2025

  • MSAC Consultation Survey - Application 1712.1

    Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care environment. It does this by providing MSAC with an insight into the potential effect of the proposed health service or... More
    Opened 2 April 2025

  • MSAC Consultation Survey - Application 1785

    Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care environment. It does this by providing MSAC with an insight into the potential effect of the proposed health service or... More
    Opened 26 February 2025

  • MSAC Consultation Survey - Application 1786

    Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care environment. It does this by providing MSAC with an insight into the potential effect of the proposed health service or... More
    Opened 26 February 2025

  • MSAC Consultation Survey - Application 1787

    Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care environment. It does this by providing MSAC with an insight into the potential effect of the proposed health service or... More
    Opened 26 February 2025
88 results. Page 1 of 3